Literature DB >> 16984702

Fibromuscular dysplasia as the substrate for systemic and pulmonary hypertension in the setting of Moya-Moya disease.

Phalla Ou1, Peggy Dupont, Damien Bonnet.   

Abstract

We report the first case, to the best of our knowledge, of a child with the unusual association of Moya-Moya disease and both systemic and pulmonary hypertension. Histological examination revealed fibromuscular dysplasia as the common denominator for a diffuse arteriopathy.

Entities:  

Mesh:

Year:  2006        PMID: 16984702     DOI: 10.1017/S104795110600045X

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  7 in total

1.  Champagne bottle neck sign in a patient with Moyamoya syndrome.

Authors:  Takafumi Shimogawa; Takato Morioka; Tetsuro Sayama; Takeshi Hamamura; Chiharu Yasuda; Shuji Arakawa
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

2.  Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Authors:  Eikan Mishima; Shu Umezawa; Takehiro Suzuki; Miki Fujimura; Michiaki Abe; Junichiro Hashimoto; Takaaki Abe; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

3.  Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.

Authors:  Hatasu Kobayashi; Risako Kabata; Hideyuki Kinoshita; Takaaki Morimoto; Koh Ono; Midori Takeda; Jungmi Choi; Hiroko Okuda; Wanyang Liu; Kouji H Harada; Takeshi Kimura; Shohab Youssefian; Akio Koizumi
Journal:  Pulm Circ       Date:  2018-05-02       Impact factor: 3.017

4.  A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous RNF213 mutation.

Authors:  Kei Takahashi; Junichi Nakamura; Shinya Sakiyama; Toshitaka Nakaya; Takahiro Sato; Taku Watanabe; Hiroshi Ohira; Keishi Makita; Utano Tomaru; Akihiro Ishizu; Ichizo Tsujino
Journal:  Respir Med Case Rep       Date:  2019-12-14

Review 5.  Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

Authors:  Yuting Luo; Zhixin Cao; Shaoqing Wu; Xunsha Sun
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

6.  Moyamoya disease with peripheral pulmonary artery stenoses and coronary artery fistulae.

Authors:  Lindsay Reardon; Andrew O Maree; Michael de Moor
Journal:  Case Rep Med       Date:  2009-05-27

7.  Atypical presentation of moyamoya disease with pulmonary hypertension: A case report.

Authors:  Mete Han Kızılkaya; Fahrettin Uysal; Emre Gürbüz; Mevlüt Özgür Taşkapılıoğlu; Özlem Mehtap Bostan
Journal:  Anatol J Cardiol       Date:  2018-05       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.